 | Up a level |
van Tilburg, Cornelis M., Milde, Till, Witt, Ruth, Ecker, Jonas, Hielscher, Thomas, Seitz, Angelika, Schenk, Jens-Peter, Buhl, Juliane L., Riehl, Dennis, Fruhwald, Michael C., Pekrun, Arnulf, Rossig, Claudia, Wieland, Regina, Flotho, Christian, Kordes, Uwe, Gruhn, Bernd, Simon, Thorsten, Linderkamp, Christin, Sahm, Felix 
ORCID: 0000-0001-5441-1962, Taylor, Lenka, Freitag, Angelika, Burhenne, Jurgen, Foerster, Kathrin I., Meid, Andreas D., Pfister, Stefan M., Karapanagiotou-Schenkel, Irini and Witt, Olaf
(2019).
Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia.
Clin. Epigenetics, 11 (1).
LONDON:
BMC.
ISSN 1868-7083
van Tilburg, Cornelis Martinus, Milde, Till, Witt, Ruth, Ecker, Jonas, Seitz, Angelika, Schenk, Jens-Peter, Fruehwald, Michael, Pekrun, Arnulf, Roessig, Claudia, Wieland, Regina, Flotho, Christian, Kordes, Uwe, Gruhn, Bernd, Simon, Thorsten, Linderkamp, Christin, Taylor, Lenka, Burhenne, Juergen, Pfister, Stefan M., Karapanagiotou-Schenkel, Irini and Witt, Olaf (2018). Phase 1/2 intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia. J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755